Skip to main content
Thermo Fisher Scientific logo
TMO.NYSE
Thermo Fisher Scientific
Healthcare · Diagnostics & Research

Global specialist in serving science enabling customers to make the world healthier, cleaner, and safer through laboratory equipment and services.

HQ: United StatesListed: United States

Profile & Fundamentals

Review the profile, reported financial history, AI financial assessment, dividends, splits, and dated events for Thermo Fisher Scientific.

Profile & Fundamentals

Thermo Fisher Scientific Profile & Fundamentals

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables
Explore this pageJump to a Profile & Fundamentals section

Company and Market Context

Company Profile & Ownership

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

TMO.NYSE

Company profile record

Thermo Fisher Scientific Inc

Common Stock · Healthcare · Diagnostics & Research

Official website

Company

Company / asset
Thermo Fisher Scientific Inc
Security type
Common Stock
Sector
Healthcare
Industry
Diagnostics & Research
HQ
🇺🇸 United States
Head office
168 Third Avenue, Waltham, MA, United States, 02451

Leadership & scale

Chief executive
Mr. Marc N. Casper
CEO year born
1968
Full-time employees
125K
Fiscal year end
December
IPO date
1978-01-13

Fundamentals snapshot

Updated 2026-07-27
Market Cap
USD 213.1B
P/E
30.5x
Revenue (Q2 26)
USD 12.0B
Profit (Q2 26)
USD 1.7B
Dividend Yield
0.2%
Revenue (FY 25)
USD 44.6B
Shares in public float
370M
Insider ownership
0.15%

Reporting & identifiers

Symbol
TMO.NYSE
Listing
🇺🇸 United States | Dividend Tax: 30%
Ticker Currency
USD
Income Statement Currency
USD
Balance Sheet Currency
USD
Cash Flow Currency
USD
EPS Currency
USD
Contract Type
SPOT
ISIN
US8835561023
Asset ID
equity_b5649eae-cacd-5a55-b622-d2acb17d1247

Ownership

Shares Outstanding

Latest: 371.0M | Max: 436.2M | Min: 361.7M

Shares Outstanding
549.6M412.2M274.8M137.4M0.00
'07
'09
'11
'13
'15
'17
'19
'21
'23
'25
'26

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open every chart, financial statement, event, and source table.